Sort
82,697 grants matching “vaccine development”
HIV Database and Analysis Unit
$2,736,540National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$2,736,516Ann R Falsey · University Of Rochester · UM1 · FY2022 · AI
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
$2,736,269James E Crowe · University Of Texas Med Br Galveston · U19 · FY2019 · AI
Aging Intervention Studies
$2,736,062Julie Mattison · National Institute On Aging · ZIA · FY2023 · AG
STAMPOUT: A Phase 2a Study of Antibody for Methamphetamine Outpatient Therapy
$2,735,856Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2018 · DA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2021 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2023 · CA
The humoral response to Zika virus infection and vaccination
$2,734,516Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Centers for AIDS Research (CFAR)
$2,733,379Kent J. Weinhold · Duke University · P30 · FY2017 · AI
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection
$2,733,163John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2016 · AI
Soweto Clinical Trials Unit
$2,732,845Glenda Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2012 · AI
The University of North Carolina Center for AIDS Research
$2,729,963Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2016 · AI
The University of North Carolina Center for AIDS Research
$2,729,963Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2017 · AI
Molecular and Immunologic Analysis of the Pathobiology of Anthrax
$2,728,833Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2006 · AI
Assays to Support Development of Malaria Transmission Blocking Vaccines
$2,728,182Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Nucleic acid vaccines targeting hantaviruses
$2,727,988Alexander Bukreyev · Vanderbilt University Medical Center · U19 · FY2024 · AI
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,726,389Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2014 · AI
Development of Novel Immunogens for Vaccines to HIV-1
$2,725,643Robert Gerald Whalen · Maxygen, Inc. · P01 · FY2008 · AI
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
$2,725,226Barbara Driver · Westat, Inc. · N01 · FY2023 · HD
Translational Research in Cancer
$2,723,515Karen E Knudsen · Thomas Jefferson University · P30 · FY2014 · CA
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$2,721,480Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2020 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$2,721,262Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2021 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$2,720,994Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2019 · AI
China's Integrated Programs for Research on AIDS
$2,720,681Yiming Shao · National Center For Aids/Std Control And Prevention · U19 · FY2006 · AI
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,720,209David W Haas · Vanderbilt University Medical Center · UM1 · FY2025 · AI